Cargando…
Adaptation‐Proof SARS‐CoV‐2 Vaccine Design
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) surface spike glycoprotein—a major antibody target—is critical for virus entry via engagement of human angiotensin‐converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the recept...
Autores principales: | Vishweshwaraiah, Yashavantha L., Hnath, Brianna, Rackley, Brendan, Wang, Jian, Gontu, Abhinay, Chandler, Morgan, Afonin, Kirill A., Kuchipudi, Suresh V., Christensen, Neil, Yennawar, Neela H., Dokholyan, Nikolay V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799234/ https://www.ncbi.nlm.nih.gov/pubmed/36590650 http://dx.doi.org/10.1002/adfm.202206055 |
Ejemplares similares
-
mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022) -
Two-input protein logic gate for computation in living cells
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2021) -
A noncommutative combinatorial protein logic circuit controls cell orientation in nanoenvironments
por: Chen, Jiaxing, et al.
Publicado: (2023) -
Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover
por: Kuchipudi, Suresh V, et al.
Publicado: (2021) -
Mitigating the Impact of Emerging Animal Infectious Disease Threats: First Emerging Animal Infectious Diseases Conference (EAIDC) Report
por: Kuchipudi, Suresh V., et al.
Publicado: (2022)